Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. See how members lowered A1C, timed Metformin ER, and optimized thyroid labs—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Diabetes, Thyroid & A1C Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Diabetes, Thyroid & A1C Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Thyroid, Adrenal & Endocrine Disorders

Thyroid, Adrenal & Endocrine Disorders (112 Condition Guides)

Hypothyroidism, Hashimoto thyroiditis, Graves disease, parathyroid, adrenal, and pituitary disorders.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Thyroid, Adrenal & Endocrine Disorders Guides (112)

Clear Filter × Page 3 of 4

Parathyroid Disorders

Most people have four pea-sized glands, called parathyroid glands, on the thyroid gland in the neck. Though their names are similar, the thyroid and parathyroid glands are completely different. The parathyroid glands make parathyroid hormone (PTH), which helps your body keep the right balance of calcium and phosphorous. If your parathyroid glands make too much or too little hormone, it disrupts this balance. If they secrete extra PTH, you have hyperparathyroidism, and your blood calcium rises. In many cases, a benign tumor on a parathyroid gland makes it overactive. Or, the extra hormones can come from enlarged parathyroid glands. Very rarely, the cause is cancer.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Parathyroid adenoma

Also called: Adenoma • Adenomatous

Parathyroid adenoma (ICD-10-CM D35.1) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Pellagra

Pellagra (ICD-10-CM E52) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Phenylketonuria (PKU)

Phenylketonuria (PKU) (ICD-10-CM E70.0) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Phosphate - high

Also called: Hyperphosphatemia

Phosphate - high (ICD-10-CM E83.39) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Phosphate - low

Also called: Hypophosphatemia

Phosphate - low (ICD-10-CM E83.39) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Pituitary Disorders

Your pituitary gland is a pea-sized gland at the base of your brain. The pituitary is the "master control gland" - it makes hormones that affect growth and the functions of other glands in the body. With pituitary disorders, you often have too much or too little of one of your hormones. Injuries can cause pituitary disorders, but the most common cause is a pituitary tumor.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Pituitary Tumors

Also called: Adenoma • Adenomatous • Fibroid

Your pituitary gland is a pea-sized gland at the base of your brain. The pituitary is the "master control gland" - it makes hormones that affect growth and the functions of other glands in the body. Pituitary tumors are common, but often they don't cause health problems. Most people with pituitary tumors never even know they have them. The most common type of pituitary tumor produces hormones and disrupts the balance of hormones in your body. This can cause endocrine diseases such as Cushing syndrome and hyperthyroidism.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Porphyria cutanea tarda

Also called: Cutis • Dermal

Porphyria cutanea tarda (ICD-10-CM E80.1) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Postinfectious hypothyroidism

Postinfectious hypothyroidism (ICD-10-CM E03.3) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Primary adrenocortical insufficiency

Primary adrenocortical insufficiency (ICD-10-CM E27.1) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Primary hyperparathyroidism

Primary hyperparathyroidism (ICD-10-CM E21.0) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Prolactin - high (hyperprolactinemia)

Also called: Hyperprolactinemia

Prolactin - high (hyperprolactinemia)—coded clinically as E22.1 across Thyroid & Endocrine guidelines—combines dynamic endocrine stimulation/suppression in Prolactin - high (hyperprolactinemia) (E22.1: testing) with structured follow-up of Morning Serum Cortisol in Prolactin - high (hyperprolactinemia) (E22.1: (8 AM)) (10 – 18 mcg/dL (E22.1)).

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Pseudohypoparathyroidism

Pseudohypoparathyroidism (ICD-10-CM E20.1) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Riedel's thyroiditis

Riedel's thyroiditis (ICD-10-CM E06.5) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Scurvy

Scurvy (ICD-10-CM E54) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Sheehan's syndrome

Sheehan's syndrome (ICD-10-CM E23.0) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Sick-euthyroid syndrome

Sick-euthyroid syndrome (ICD-10-CM E07.81) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Subacute thyroiditis

Subacute thyroiditis (ICD-10-CM E06.1) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Subclinical iodine-deficiency hypothyroidism

Subclinical iodine-deficiency hypothyroidism (ICD-10-CM E02) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thiamine (vitamin B1) deficiency

Also called: Thiamine deficiency • Thiamine • Vitamin b1

Thiamine (vitamin B1) deficiency—coded clinically as E51.9 across Thyroid & Endocrine guidelines—combines autoimmune antibody titers [Thiamine (vitamin B1) deficiency E51.9] with structured follow-up of Thyroid-Stimulating Hormone (TSH) [Thiamine (vitamin B1) deficiency E51.9] (0.8 – 2.5 mIU/L (E51.9)).

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thyroid Diseases

Also called: Goiter

Your thyroid is a small, butterfly-shaped gland in the front of your neck. It makes hormones that control the way the body uses energy. These hormones affect nearly every organ in your body and control many of your body's most important functions. For example, they affect your breathing, heart rate, weight, digestion, and moods. Thyroid diseases cause your thyroid to make either too much or too little of the hormones.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thyroid Tests

Your thyroid is a small, butterfly-shaped gland in the front of your neck. It makes hormones that control the way the body uses energy. These hormones affect nearly every organ in your body and control many of your body's most important functions. For example, they affect your breathing, heart rate, weight, digestion, and moods. Thyroid tests check how well your thyroid is working. They are also used to diagnose and help find the cause of thyroid diseases such as hyperthyroidism and hypothyroidism. Thyroid tests include blood tests and imaging tests. Blood tests for your thyroid include: TSH. It measures thyroid-stimulating hormone.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thyroid adenoma

Also called: Adenoma • Adenomatous

Thyroid adenoma (ICD-10-CM D34) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Thyroid bruit

Thyroid bruit (ICD-10-CM R09.89) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Thyroid nodule

Also called: Nodule • Nodular • Multinodular

Thyroid nodule—coded clinically as E04.1 across Thyroid & Endocrine guidelines—combines electrolyte-mineral balance monitoring [Thyroid nodule E04.1] with structured follow-up of Morning Serum Cortisol in Thyroid nodule (E04.1: (8 AM)) (10 – 18 mcg/dL (E04.1)).

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thyroid nodule - hot

Also called: Nodule • Nodular • Multinodular

Thyroid nodule - hot (ICD-10-CM E04.1) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thyroiditis

Thyroiditis (ICD-10-CM E06.9) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thyrotoxicosis from ectopic thyroid tissue with thyrotoxic crisis or storm

Thyrotoxicosis from ectopic thyroid tissue with thyrotoxic crisis or storm (ICD-10-CM E05.31) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm

Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm—coded clinically as E05.30 across Thyroid & Endocrine guidelines—combines electrolyte-mineral balance monitoring [Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm E05.30] with structured follow-up of Thyroid-Stimulating Hormone (TSH) [Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm E05.30] (0.8 – 2.5 mIU/L (E05.30)).

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm

Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm (ICD-10-CM E05.21) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm

Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm (ICD-10-CM E05.20) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm

Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm (ICD-10-CM E05.10) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Thyroid, Adrenal & Endocrine Disorders on dotMD.com?

dotMD.com maps Thyroid, Adrenal & Endocrine Disorders against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Thyroid, Adrenal & Endocrine Disorders visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee